Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
PARNAXLAB.BOthis companyParnax Lab Limited	₹107.05	12.52×	1.55×	0.59×	7.75×	-462.0%	26.7%	7.7%	4.7%	12.4%	7.7%	-22.4%	0.87×	2.78×	3.36×	0.97×	0.0%	3	—	2	C+
ALPA.NSAlpa Laboratories Limited	₹56.58	6.52×	0.52×	0.92×	5.12×	43.1%	12.9%	1.1%	14.2%	8.1%	0.6%	8.7%	0.01×	-0.02×	4.64×	4.01×	0.0%	5	—	2	B-
COLINZ.BOColinz Laboratories Limited	₹70.00	21.81×	1.12×	1.83×	7.57×	-17.6%	25.6%	4.1%	8.4%	5.1%	1.8%	28.8%	0.04×	-19.97×	5.39×	3.93×	0.0%	4	7.16	5	S-
CONCORD.BOConcord Drugs Limited	₹72.72	83.11×	1.8×	1.11×	22.15×	-217.1%	14.1%	4.0%	1.3%	2.2%	3.5%	-9.1%	0.28×	2.93×	1.86×	2.53×	0.0%	4	—	2	C
CORALAB.BOCoral Laboratories Limited	₹533.50	8.08×	0.63×	1.54×	2.52×	7.4%	37.6%	15.2%	19.1%	7.8%	4.3%	-6.3%	0.02×	-2.68×	76.29×	6.48×	0.4%	2	—	3	B
DECIPHER.BODecipher Labs Ltd.	₹5.60	-1.71×	0.26×	0.38×	-1.49×	-90.6%	95.4%	-27.8%	-21.9%	-14.9%	-15.4%	-44.0%	0.02×	0.07×	0×	5.22×	0.0%	3	—	2	C
Peer median	—	8.08×	0.63×	1.11×	5.12×	-17.6%	25.6%	4.0%	8.4%	5.1%	1.8%	-6.3%	0.02×	-0.02×	4.64×	4.01×	0.0%	4	7.16	2	—